Journal for ImmunoTherapy of Cancer (Nov 2020)

301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study

  • Ralf Gutzmer,
  • Caroline Robert,
  • Thomas Eigentler,
  • Qian Zhu,
  • Helen Gogas,
  • Grant McArthur,
  • Paolo Ascierto,
  • Daniil Stroyakovskiy,
  • Svetlana Protsenko,
  • Rodrigo Pereira,
  • Lev Demidov,
  • Georgy Moiseevich Manikhas,
  • Haocheng Li,
  • Edward McKenna,
  • Virginia McNally

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0301
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.